CXCR2 is a novel cancer stem-like cell marker for triple-negative breast cancer.
Wang Y, Tu L, Du C, Xie X, Liu Y, Wang J, Li Z, Jiang M, Cao D, Yan X, Luo F.
Wang Y, et al. Among authors: yan x.
Onco Targets Ther. 2018 Sep 6;11:5559-5567. doi: 10.2147/OTT.S174329. eCollection 2018.
Onco Targets Ther. 2018.
PMID: 30233217
Free PMC article.